Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies

J Neurol. 2000 Oct;247(10):767-72. doi: 10.1007/s004150070090.

Abstract

Thirty-two patients with a peripheral neuropathy and paraproteinemia were tested for IgM antibodies against myelin-associated protein (MAG) and sulfatide by means of enzyme-linked immunosorbent assay. Nine patients (28 %) had increased anti-sulfatide IgM antibodies and showed a chronic, slowly progressive, distally pronounced, and symmetric polyneuropathy with sensory to sensory-motor impairment, ataxia, hyporeflexia, and axonal involvement in electrophysiological studies. Ten patients (31 %) with increased anti-MAG antibodies had a similar, homogeneous polyneuropathy syndrome but presented with demyelinating features. A weak cross-reactivity between anti-MAG and anti-sulfatide antibodies was present in only three patients. In conclusion, although the two neuropathy groups clearly differed in their electrophysiological features, their clinical presentation was rather similar.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Disease Progression
  • Electrophysiology
  • Female
  • Humans
  • Immunoglobulin M / immunology*
  • Male
  • Middle Aged
  • Motor Skills Disorders
  • Myelin-Associated Glycoprotein / analysis
  • Myelin-Associated Glycoprotein / immunology*
  • Peripheral Nervous System Diseases / immunology*
  • Peripheral Nervous System Diseases / physiopathology

Substances

  • Immunoglobulin M
  • Myelin-Associated Glycoprotein